Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Pamela Haig"'
Autor:
Karin Purshouse, John P Thomson, Mahéva Vallet, Lorna Alexander, Isaac Bonisteel, Maree Brennan, David A Cameron, Jonine D Figueroa, Elizabeth Furrie, Pamela Haig, Mattea Heck, Hugh McCaughan, Paul Mitchell, Heather McVicars, Lorraine Primrose, Ines Silva, Kate Templeton, Natalie Wilson, Peter S Hall
Publikováno v:
Purshouse, K, Thomson, J P, Vallet, M, Alexander, L, Bonisteel, I, Brennan, M, Cameron, D A, Figueroa, J D, Furrie, E, Haig, P, Heck, M, Mccaughan, H, Mitchell, P, Mcvicars, H, Primrose, L, Silva, I, Templeton, K, Wilson, N & Hall, P S 2023, ' The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti–Cancer Treatment ', The Oncologist . https://doi.org/10.1093/oncolo/oyac257, https://doi.org/10.1093/oncolo/oyac257
Background Cancer and anti-cancer treatment (ACT) may be risk factors for severe SARS-CoV-2 infection and limited vaccine efficacy. Long–term longitudinal studies are needed to evaluate these risks. The Scottish COVID cancer immunity prevalence (SC
Autor:
Karin Purshouse, John P Thomson, Mahéva Vallet, Lorna Alexander, Isaac Bonisteel, Maree Brennan, David A Cameron, Jonine D Figueroa, Elizabeth Furrie, Pamela Haig, Mattea Heck, Hugh McCaughan, Paul Mitchell, Heather McVicars, Lorraine Primrose, Kate Templeton, Natalie Wilson, Peter S Hall
Publikováno v:
Journal of Clinical Oncology. 40:e18733-e18733
BackgroundCancer and systemic anti-cancer treatment (SACT) have been identified as possible risk factors for infection and related severe illness associated with SARS-CoV-2 virus as a consequence of immune suppression. The Scottish COVID CAncer iMmun